These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 36674535)

  • 21. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
    J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic Neuropathy of the Retina and Inflammation: Perspectives.
    Bikbova G; Oshitari T; Bikbov M
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Liou GI; Caldwell RW
    Curr Drug Targets; 2005 Jun; 6(4):511-24. PubMed ID: 16026270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy.
    Xu J; Chen LJ; Yu J; Wang HJ; Zhang F; Liu Q; Wu J
    Cell Physiol Biochem; 2018; 48(2):705-717. PubMed ID: 30025404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological Perturbations in Diabetic Retinopathy: Hyperglycemia, AGEs, Oxidative Stress and Inflammatory Pathways.
    Sahajpal NS; Goel RK; Chaubey A; Aurora R; Jain SK
    Curr Protein Pept Sci; 2019; 20(1):92-110. PubMed ID: 30264677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment.
    Abcouwer SF; Gardner TW
    Ann N Y Acad Sci; 2014 Apr; 1311():174-90. PubMed ID: 24673341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications.
    Semeraro F; Morescalchi F; Cancarini A; Russo A; Rezzola S; Costagliola C
    Diabetes Metab; 2019 Dec; 45(6):517-527. PubMed ID: 31005756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
    Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
    Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of FAM18B in diabetic retinopathy.
    Wang AL; Rao VR; Chen JJ; Lussier YA; Rehman J; Huang Y; Jager RD; Grassi MA
    Mol Vis; 2014; 20():1146-59. PubMed ID: 25221423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent Advancements in the Medical Treatment of Diabetic Retinal Disease.
    Szymanska M; Mahmood D; Yap TE; Cordeiro MF
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
    Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
    Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroinflammation and neovascularization in diabetic eye diseases (DEDs): identification of potential pharmacotherapeutic targets.
    Panda SP; Reddy PH; Gorla US; Prasanth D
    Mol Biol Rep; 2023 Feb; 50(2):1857-1869. PubMed ID: 36513866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-15b Targets VEGF and Inhibits Angiogenesis in Proliferative Diabetic Retinopathy.
    Yang Y; Liu Y; Li Y; Chen Z; Xiong Y; Zhou T; Tao W; Xu F; Yang H; Ylä-Herttuala S; Chaurasia SS; Adam WC; Yang K
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3404-15. PubMed ID: 32797181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Diabetic Retinopathy in Two Mouse Models and Response to a Single Injection of Anti-Vascular Endothelial Growth Factor.
    Azrad-Leibovich T; Zahavi A; Gohas MF; Brookman M; Barinfeld O; Muhsinoglu O; Michowiz S; Fixler D; Goldenberg-Cohen N
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pathogenesis of diabetic retinopathy: old concepts and new questions.
    Cai J; Boulton M
    Eye (Lond); 2002 May; 16(3):242-60. PubMed ID: 12032713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of inflammatory cells in pathophysiology and management of diabetic retinopathy.
    Kovoor E; Chauhan SK; Hajrasouliha A
    Surv Ophthalmol; 2022; 67(6):1563-1573. PubMed ID: 35914582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy.
    Wan TT; Li XF; Sun YM; Li YB; Su Y
    Biomed Pharmacother; 2015 Aug; 74():145-7. PubMed ID: 26349976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of the Chinese herbal medicine prescription Zhujing pill on retina of streptozotocin-induced diabetic rats.
    Lei X; He J; Ren C; Zhou Y; Chen X; Dou J
    Biomed Pharmacother; 2018 Feb; 98():643-650. PubMed ID: 29289839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. pEPito-driven PEDF Expression Ameliorates Diabetic Retinopathy Hallmarks.
    Calado SM; Diaz-Corrales F; Silva GA
    Hum Gene Ther Methods; 2016 Apr; 27(2):79-86. PubMed ID: 26942449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.